rs688

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -17 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_StrongBP6_StrongBP7

The NM_000527.5(LDLR):c.1773C>T (p.Asn591Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.417 (AC=673,211) in the gnomAD database across 1,613,584 control chromosomes, including 147,093 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.446. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 10427 hom., cov: 31)
Exomes 𝑓: 0.43 ( 136666 hom. )

Consequence

LDLR
NM_000527.5 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:23

Conservation

PhyloP100: -4.22

Publications

206 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Natera
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000527.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -17 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BP6
ClinVar 2-star benign — strong (BP6); ClinVar submissions overwhelmingly benign (≥10 total, ≥80% B/LB, <10% P/LP) — strong (BP6, count-based); ClinVar germline classification: Benign/Likely Benign, 2 star(s). ClinVar submissions strongly and reliably favor benignity (23/23 total B/LB).
BP7
Synonymous variant at non-conserved position with no predicted splicing impact (BP7); Synonymous at non-conserved position, no splicing concern — benign (BP7).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4456 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.1773C>Tp.Asn591Asn
synonymous
Exon 12 of 18NP_000518.1P01130-1
LDLR
NM_001195798.2
c.1773C>Tp.Asn591Asn
synonymous
Exon 12 of 18NP_001182727.1P01130-5
LDLR
NM_001195799.2
c.1650C>Tp.Asn550Asn
synonymous
Exon 11 of 17NP_001182728.1P01130-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.1773C>Tp.Asn591Asn
synonymous
Exon 12 of 18ENSP00000454071.1P01130-1
LDLR
ENST00000252444.10
TSL:1
c.2031C>Tp.Asn677Asn
synonymous
Exon 12 of 18ENSP00000252444.6J3KMZ9
LDLR
ENST00000558013.5
TSL:1
c.1773C>Tp.Asn591Asn
synonymous
Exon 12 of 18ENSP00000453346.1P01130-5

Frequencies

GnomAD3 genomes
AF:
0.337
AC:
51230
AN:
151818
Hom.:
10439
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.349
Gnomad AMR
AF:
0.427
Gnomad ASJ
AF:
0.419
Gnomad EAS
AF:
0.173
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.493
Gnomad MID
AF:
0.434
Gnomad NFE
AF:
0.437
Gnomad OTH
AF:
0.362
GnomAD2 exomes
AF:
0.389
AC:
97866
AN:
251472
AF XY:
0.396
show subpopulations
Gnomad AFR exome
AF:
0.100
Gnomad AMR exome
AF:
0.415
Gnomad ASJ exome
AF:
0.432
Gnomad EAS exome
AF:
0.179
Gnomad FIN exome
AF:
0.483
Gnomad NFE exome
AF:
0.434
Gnomad OTH exome
AF:
0.409
GnomAD4 exome
AF:
0.426
AC:
622001
AN:
1461646
Hom.:
136666
Cov.:
43
AF XY:
0.425
AC XY:
309181
AN XY:
727136
show subpopulations
African (AFR)
AF:
0.0953
AC:
3192
AN:
33478
American (AMR)
AF:
0.419
AC:
18718
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.435
AC:
11369
AN:
26136
East Asian (EAS)
AF:
0.148
AC:
5861
AN:
39700
South Asian (SAS)
AF:
0.393
AC:
33938
AN:
86252
European-Finnish (FIN)
AF:
0.472
AC:
25193
AN:
53410
Middle Eastern (MID)
AF:
0.448
AC:
2581
AN:
5758
European-Non Finnish (NFE)
AF:
0.447
AC:
496547
AN:
1111798
Other (OTH)
AF:
0.407
AC:
24602
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
21002
42004
63007
84009
105011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14828
29656
44484
59312
74140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.337
AC:
51210
AN:
151938
Hom.:
10427
Cov.:
31
AF XY:
0.341
AC XY:
25314
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.107
AC:
4420
AN:
41494
American (AMR)
AF:
0.426
AC:
6484
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
1452
AN:
3468
East Asian (EAS)
AF:
0.172
AC:
890
AN:
5160
South Asian (SAS)
AF:
0.393
AC:
1894
AN:
4820
European-Finnish (FIN)
AF:
0.493
AC:
5197
AN:
10538
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.437
AC:
29676
AN:
67940
Other (OTH)
AF:
0.360
AC:
755
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1569
3139
4708
6278
7847
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
504
1008
1512
2016
2520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
TOPMed (Bravo)
AF:
0.321
AC:
84921
AN:
264690
Hom.:
16478
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF:
0.400
AC:
182117
AN:
455066
Hom.:
38700

Local populations

ABraOM SABE-WGS-1171
AF:
0.355
AC:
832
AN:
2342
Hom.:
162
ChinaMAP Phase 1
AF:
0.167
Denmark Genome
AF:
0.420
AC:
126
AN:
300
ESP6500 (Exome Variant Server)
AF:
0.335
AC:
4360
AN:
13006
show subpopulations
European American
AF:
0.450
AC:
3874
AN:
8600
African American
AF:
0.110
AC:
486
AN:
4406
GenomeAsia100K
AF:
0.266
AC:
923
AN:
3478
show subpopulations
Oceania
AF:
0.446
AC:
66
AN:
148
Hom.:
17
North-East Asia
AF:
0.171
AC:
120
AN:
702
Hom.:
18
South-East Asia
AF:
0.257
AC:
178
AN:
692
Hom.:
28
South Asia
AF:
0.297
AC:
430
AN:
1448
Hom.:
63
Africa
AF:
0.0481
AC:
10
AN:
208
Hom.:
0
America
AF:
0.288
AC:
15
AN:
52
Hom.:
4
West Eurasia
AF:
0.456
AC:
104
AN:
228
Hom.:
25
Korea4K (4,157 Koreans)
AF:
0.144
AC:
1040
AN:
7232
Qatari Genome
AF:
0.481
AC:
965
AN:
2008
ToMMo 61KJPN (+60KJPN MNV)
AF:
0.121
AC:
14833
AN:
122156
Hom.:
951
Turkish Variome
AF:
0.407
AC:
2735
AN:
6718
Hom.:
591
UK10K
AF:
0.449
AC:
3392
AN:
7562
show subpopulations
TwinsUK
AF:
0.444
AC:
1588
AN:
3574
ALSPAC
AF:
0.452
AC:
1743
AN:
3854
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.170
AC:
1524
AN:
8960
Hom.:
133

Case/control cohorts

Cohort
Cases
Controls
ASC
(Autism)
4592 / 11098AF: 0.413768
7244 / 17604AF: 0.411497
BipEx
(Bipolar disorder (including schizoaffective))
12447 / 28420AF: 0.437966
12635 / 28844AF: 0.438046
Epi25
(Epilepsy)
16330 / 41956AF: 0.389217
27121 / 66882AF: 0.405505
SCHEMA
(Schizophrenia)
41202 / 131958AF: 0.312236
69948 / 212874AF: 0.328589

Allele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
9
Hypercholesterolemia, familial, 1 (9)
-
-
7
not specified (7)
-
-
4
Familial hypercholesterolemia (4)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.092
DANN
Benign
0.70
PhyloP100
-4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
AlphaGenome AVI
Benign
0.00076
GPN-Star LLR
-0.71
GPN-Star score
0.45
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2
Pangolin (max)
Benign
0.0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs688;
hg19: chr19-11227602;
COSMIC: COSV52942945;
COSMIC: COSV52942945;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.